首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1673643

神經血管導管市場規模、佔有率及成長分析（按類型、組件、應用、最終用途和地區）－2025-2032 年產業預測

Neurovascular Catheters Market Size, Share, and Growth Analysis, By Type (Microcatheters, Balloon Catheters), By Component (Catheter Mandrels, Catheter Liners), By Application, By End-use, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年神經血管導管市場規模為 32.5 億美元，預計將從 2024 年的 34.8 億美元成長到 2032 年的 60.8 億美元，預測期內（2025-2032 年）的複合年成長率為 7.2%。

根據市場洞察，腦動脈瘤和中風等神經系統疾病的增加、不健康的生活方式選擇以及公眾對治療方案的認知不斷提高，正在推動神經血管領域的強勁成長。全球蛛網膜下腔出血（SAH）的發生率約為每十萬人 6.67 人，每年影響超過 50 萬人，主要發生在中低收入地區。此外，技術進步，尤其是神經血管導管技術的進步，正在推動市場擴張。特別是，Serenovas於2022年2月推出了EMBOGUARD血管內治療導管，以增強急性缺血性腦中風的治療效果。隨著調查方法不斷證實各種神經血管通路技術的安全性和有效性，為創新解決方案鋪路預計將在預測期內推動市場成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Medtronic（Galway, Ireland）
Boston Scientific（Marlborough, Massachusetts, USA）
Stryker Corporation（Kalamazoo, Michigan, USA）
Penumbra（Alameda, California, USA）
Edwards Lifesciences（Irvine, California, USA）
Terumo Corporation（Tokyo, Japan）
Johnson & Johnson（New Brunswick, New Jersey, USA）
Abbott Laboratories（Abbott Park, Illinois, USA）
B. Braun Melsungen（Melsungen, Germany）
MicroPort Scientific（Shanghai, China）
Integer Holdings Corporation（Plano, Texas, USA）
Cook Medical（Bloomington, Indiana, USA）
Cardinal Health（Dublin, Ohio, USA）
Smith & Nephew（London, United Kingdom）
Teleflex Incorporated（Wayne, Pennsylvania, USA）
Merit Medical Systems（South Jordan, Utah, USA）
Nipro Corporation（Osaka, Japan）
Asahi Intecc（Aichi, Japan）
WL Gore & Associates（Newark, Delaware, USA）
Convatec（London, United Kingdom）

結論和建議

簡介目錄

Product Code: SQMIG35A2523

Neurovascular Catheters Market size was valued at USD 3.25 billion in 2023 and is poised to grow from USD 3.48 billion in 2024 to USD 6.08 billion by 2032, growing at a CAGR of 7.2% during the forecast period (2025-2032).

Market insights indicate robust growth in the neurovascular sector, driven by increasing incidences of neurological disorders such as brain aneurysms and strokes, alongside unhealthy lifestyle choices and heightened public awareness regarding treatment options. The global incidence of subarachnoid hemorrhage (SAH) stands at approximately 6.67 per 100,000 individuals, with over 500,000 affected annually, predominantly in low- and middle-income regions. Furthermore, technological advancements, particularly in neurovascular catheter technology, are set to fuel market expansion. Notably, CERENOVUS launched the EMBOGUARD catheter for endovascular procedures in February 2022, enhancing treatment efficacy for acute ischemic strokes. Research continues to affirm the safety and effectiveness of various neurovascular access methodologies, paving the way for innovative solutions and contributing to the anticipated market growth during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Catheters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Catheters Market Segments Analysis

Global Neurovascular Catheters Market is segmented by Type, Component, Application, End-use and region. Based on Type, the market is segmented into Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters and Others. Based on Component, the market is segmented into Catheter Mandrels, Catheter Liners, Reflow Heat Shrinks, Nylon Tubing/Pebax and Other Components. Based on Application, the market is segmented into Embolic Stroke, Brain Aneurysm, Arteriovenous Malformations and Others. Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Catheters Market

The growing incidence of neurological conditions, including strokes, aneurysms, and arteriovenous malformations (AVMs), significantly contributes to the rising demand for neurovascular catheters. These specialized catheters play a crucial role in both the diagnosis and treatment of such disorders. As the number of individuals affected by these neurological issues continues to rise, the need for effective intervention tools like neurovascular catheters becomes increasingly critical, thereby fueling market growth. This upward trend in neurological disorders underscores the essential nature of these medical devices and propels the demand for advancements and innovations within the neurovascular catheter market.

Restraints in the Neurovascular Catheters Market

The neurovascular catheters market faces significant challenges due to the potential complications associated with their use. Operating within the intricate network of blood vessels in the brain presents risks such as bleeding, clotting, vessel perforation, and infections. These complications can result in serious neurological impairments or, in extreme cases, fatalities. Additionally, they may prolong hospital stays and escalate healthcare expenses. Patients with pre-existing medical conditions are particularly susceptible to these risks, further complicating the clinical landscape. Consequently, such factors can act as restraints on the growth and adoption of neurovascular catheters in clinical practices.

Market Trends of the Neurovascular Catheters Market

The neurovascular catheters market is experiencing robust growth, propelled by the rising prevalence of neurological disorders such as strokes, aneurysms, and arteriovenous malformations. The World Health Organization (WHO) highlights that stroke ranks as the second leading cause of death worldwide, intensifying the urgency for advanced therapeutic solutions. An increasing aging population, coupled with greater awareness and diagnosis of neurological conditions, is further driving market demand. Innovations in catheter technology, including enhanced navigation and precision delivery systems, are also shaping the market landscape. Together, these dynamics position the neurovascular catheters market for substantial growth in the coming years, as healthcare providers seek effective interventions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis

Global Neurovascular Catheters Market Size by Type & CAGR (2025-2032)

Market Overview
Microcatheters
Balloon Catheters
Access Catheters
Embolization Catheters
Others

Global Neurovascular Catheters Market Size by Component & CAGR (2025-2032)

Market Overview
Catheter Mandrels
Catheter Liners
Reflow Heat Shrinks
Nylon Tubing/Pebax
Other Components

Global Neurovascular Catheters Market Size by Application & CAGR (2025-2032)

Market Overview
Embolic Stroke
Brain Aneurysm
Arteriovenous Malformations
Others

Global Neurovascular Catheters Market Size by End-use & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Centers

Global Neurovascular Catheters Market Size & CAGR (2025-2032)

North America (Type, Component, Application, End-use)
- US
- Canada
Europe (Type, Component, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Component, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Component, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Component, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic (Galway, Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific (Marlborough, Massachusetts, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (Kalamazoo, Michigan, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra (Alameda, California, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences (Irvine, California, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Tokyo, Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (New Brunswick, New Jersey, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (Abbott Park, Illinois, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen (Melsungen, Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific (Shanghai, China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (Plano, Texas, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (Bloomington, Indiana, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (Dublin, Ohio, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew (London, United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (Wayne, Pennsylvania, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems (South Jordan, Utah, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Osaka, Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc (Aichi, Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates (Newark, Delaware, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Convatec (London, United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments